Abstract
The eternal or ultimate goal of medicinal chemistry is to find most effective ways to treat various diseases and extend human beings’ life as long as possible. Human being is a biological entity. To realize such an ultimate goal, the inputs or breakthroughs from the advances in biological science are no doubt most important that may even drive medicinal science into a revolution. In this review article, we are to address this from several different angles.
Keywords: Biomacromolecules, Low-frequency internal motions, Viroporin, Oligomerizes, Transmembrane, Encephalomyopathy, PseAAC/PseKNC, Web-server.
Current Topics in Medicinal Chemistry
Title:An Unprecedented Revolution in Medicinal Chemistry Driven by the Progress of Biological Science
Volume: 17 Issue: 21
Author(s): Kuo-Chen Chou*
Affiliation:
- Gordon Life Science Institute, Boston, Massachusetts 02478,United States
Keywords: Biomacromolecules, Low-frequency internal motions, Viroporin, Oligomerizes, Transmembrane, Encephalomyopathy, PseAAC/PseKNC, Web-server.
Abstract: The eternal or ultimate goal of medicinal chemistry is to find most effective ways to treat various diseases and extend human beings’ life as long as possible. Human being is a biological entity. To realize such an ultimate goal, the inputs or breakthroughs from the advances in biological science are no doubt most important that may even drive medicinal science into a revolution. In this review article, we are to address this from several different angles.
Export Options
About this article
Cite this article as:
Chou Kuo-Chen*, An Unprecedented Revolution in Medicinal Chemistry Driven by the Progress of Biological Science, Current Topics in Medicinal Chemistry 2017; 17 (21) . https://dx.doi.org/10.2174/1568026617666170414145508
DOI https://dx.doi.org/10.2174/1568026617666170414145508 |
Print ISSN 1568-0266 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4294 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Blood-Brain Barrier Transport of Drugs for the Treatment of Brain Diseases
CNS & Neurological Disorders - Drug Targets Cisplatin Resistance and Transcription Factors
Current Medicinal Chemistry - Anti-Cancer Agents Management of Postoperative Nausea and Vomiting in Women Undergoing Major Gynecological Surgery: A Review and Update
Current Drug Therapy PPARγ and Its Ligands: Potential Antitumor Agents in the Digestive System
Current Stem Cell Research & Therapy Threes Company: Regulation of Cell Fate by Statins
Current Drug Targets - Cardiovascular & Hematological Disorders Minifish Shows High Genetic Variation in mtDNA Size
Current Molecular Medicine STAT3 as a Central Regulator of Tumor Metastases
Current Molecular Medicine Cytotoxic Tumor-Targeting Peptides From In Vivo Phage Display
Combinatorial Chemistry & High Throughput Screening Peroxisome Proliferator Activated Receptor α Ligands as Anticancer Drugs Targeting Mitochondrial Metabolism
Current Pharmaceutical Biotechnology New Insights into the Treatment of Multiple Myeloma with Histone Deacetylase Inhibitors
Current Pharmaceutical Design Denoising Medical Images Using Machine Learning, Deep Learning Approaches: A Survey
Current Medical Imaging siRNA Delivery by Stimuli-Sensitive Nanocarriers
Current Pharmaceutical Design Metformin for Prevention and Treatment of Colon Cancer: A Reappraisal of Experimental and Clinical Data
Current Drug Targets NF-κB Blockers Gifted by Mother Nature: Prospectives in Cancer Cell Chemosensitization
Current Pharmaceutical Design The Return of the INGs, Histone Mark Sensors and Phospholipid Signaling Effectors
Current Drug Targets PCL/PEG Copolymeric Nanoparticles: Potential Nanoplatforms for Anticancer Agent Delivery
Current Drug Targets A Review on Poly (ADP-ribose) Polymerase (PARP) Inhibitors and Synthetic Methodologies
Current Medicinal Chemistry N-Substituted-2-butyl-5-chloro-3H-imidazole-4-carbaldehyde Derivatives as Anti-tumor Agents Against Ehrlich Ascites tumor Cells In Vivo
Medicinal Chemistry Metabolic Profiling in Disease Diagnosis, Toxicology and Personalized Healthcare
Current Pharmaceutical Biotechnology PI3K/Akt Signalling Pathway Specific Inhibitors: A Novel Strategy to Sensitize Cancer Cells to Anti-Cancer Drugs
Current Pharmaceutical Design